1. Home
  2. LMND vs GKOS Comparison

LMND vs GKOS Comparison

Compare LMND & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lemonade Inc.

LMND

Lemonade Inc.

HOLD

Current Price

$64.31

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$107.89

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMND
GKOS
Founded
2015
1998
Country
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LMND
GKOS
Price
$64.31
$107.89
Analyst Decision
Hold
Strong Buy
Analyst Count
9
14
Target Price
$60.22
$132.00
AVG Volume (30 Days)
2.7M
818.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$40.24
$33.04
Revenue Next Year
$59.95
$22.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.31
$73.16
52 Week High
$99.90
$161.78

Technical Indicators

Market Signals
Indicator
LMND
GKOS
Relative Strength Index (RSI) 36.90 40.71
Support Level $59.80 $105.37
Resistance Level $76.33 $115.19
Average True Range (ATR) 6.02 4.91
MACD -2.33 -1.48
Stochastic Oscillator 13.48 11.57

Price Performance

Historical Comparison
LMND
GKOS

About LMND Lemonade Inc.

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: